FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 4.0.3  |  FHIR Version n/a  User: [n/a]

38112003: 1 (qualifier value)

    Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2023. Module: SNOMED CT core module

    Descriptions:

    Id Description Lang Type Status Case? Module
    64719019 One en Synonym Active Entire term case insensitive SNOMED CT core module
    771016011 One (qualifier value) en Fully specified name Inactive Only initial character case insensitive SNOMED CT core module
    3442104013 1 (qualifier value) en Fully specified name Active Entire term case insensitive SNOMED CT core module
    3442105014 1 en Synonym Active Entire term case insensitive SNOMED CT core module

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    1 Is a General adjectival modifier false Inferred relationship Existential restriction modifier
    1 Is a Number false Inferred relationship Existential restriction modifier
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Product containing precisely gemcitabine (as gemcitabine hydrochloride) 200 milligram/1 vial powder for conventional release solution for injection Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely ketotifen 1 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely amitriptyline hydrochloride 10 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely doripenem (as doripenem monohydrate) 500 milligram/1 vial powder for conventional release solution for injection Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely phenindione 10 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely aztreonam 1 gram/1 vial powder for conventional release solution for injection Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely desmopressin acetate 200 microgram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely metoprolol tartrate 100 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely imiglucerase 200 unit/1 vial powder for conventional release solution for injection Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely cefpirome (as cefpirome sulfate) 1 gram/1 vial powder for conventional release solution for injection Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely gentamicin (as gentamicin sulfate) 3 milligram/1 milliliter conventional release solution for ear or eye drops Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely potassium aminobenzoate 500 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely colchicine 500 microgram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely fusidic acid 50 milligram/1 milliliter conventional release oral suspension Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely doxepin hydrochloride 50 milligram/1 gram conventional release cutaneous cream Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely tropicamide 5 milligram/1 milliliter conventional release eye drops Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely flutamide 250 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely memantine hydrochloride 10 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely tranexamic acid 500 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely sulpiride 400 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely ciprofibrate 100 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely silodosin 8 milligram/1 each conventional release oral capsule Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely celecoxib 100 milligram/1 each conventional release oral capsule Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely amobarbital 50 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely temazepam 10 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely diloxanide furoate 500 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely ropinirole (as ropinirole hydrochloride) 5 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely sitagliptin (as sitagliptin phosphate) 100 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Mexiletine hydrochloride 200mg capsules Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely pomalidomide 2 milligram/1 each conventional release oral capsule Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely abacavir 300 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely dequalinium chloride 250 microgram/1 each conventional release oromucosal lozenge Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely pentosan polysulfate sodium 100 milligram/1 each conventional release oral capsule Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely tenoxicam 20 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely cilostazol 50 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely tryptophan 500 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely risperidone 1 milligram/1 milliliter conventional release oral solution Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely fluconazole 150 milligram/1 each conventional release oral capsule Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely diethylstilbestrol 1 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely flavoxate hydrochloride 200 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely naproxen 500 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely nystatin 100000 unit/1 gram conventional release cutaneous ointment Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely gemfibrozil 600 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely fenbufen 450 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely enalapril maleate 2.5 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely mianserin hydrochloride 20 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely hydroxyzine hydrochloride 10 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely bromocriptine (as bromocriptine mesilate) 10 milligram/1 each conventional release oral capsule (clinical drug) Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely azathioprine 50 milligram/1 vial powder for conventional release solution for injection Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely tioguanine 40 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely nitazoxanide 20 milligram/1 milliliter conventional release oral suspension Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely lidocaine hydrochloride 20 milligram/1 milliliter conventional release cutaneous gel Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely haloperidol 5 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely trazodone hydrochloride 100 milligram/1 each conventional release oral capsule Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely ergometrine maleate 500 microgram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely paricalcitol 4 microgram/1 each conventional release oral capsule Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely cefalexin hydrochloride 500 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely cefradine 250 milligram/1 each conventional release oral capsule Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely isotretinoin 500 microgram/1 gram conventional release cutaneous gel Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely telithromycin 400 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely bromocriptine (as bromocriptine mesilate) 1 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely ciprofloxacin (as ciprofloxacin hydrochloride) 3 milligram/1 milliliter conventional release eye drops Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely travoprost 40 microgram/1 milliliter conventional release eye drops Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely maraviroc 150 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely ketotifen (as ketotifen fumarate) 250 microgram/1 milliliter conventional release eye drops Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely tetracycline hydrochloride 2.2 milligram/1 milliliter conventional release cutaneous solution Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely ponatinib (as ponatinib hydrochloride) 45 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely aripiprazole 5 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely afatinib dimaleate 40 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely phenindione 25 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely donepezil hydrochloride 10 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely hydrocortisone acetate 5 milligram/1 gram conventional release eye ointment Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely topiramate 50 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely chlorpromazine hydrochloride 100 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely prazosin (as prazosin hydrochloride) 2 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely nabilone 1 milligram/1 each conventional release oral capsule Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely aztreonam 500 milligram/1 vial powder for conventional release solution for injection Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely colistimethate sodium 1 million unit/1 vial powder for conventional release solution for injection Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely ibuprofen 50 milligram/1 gram conventional release cutaneous gel Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely fluorouracil 5 milligram/1 gram conventional release cutaneous cream Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely auranofin 3 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely fludroxycortide 125 microgram/1 gram conventional release cutaneous cream Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely diazepam 10 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely ondansetron 8 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely nicotinamide 40 milligram/1 gram conventional release cutaneous gel Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely indinavir (as indinavir sulfate) 333 milligram/1 each conventional release oral capsule Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely cefazolin (as cefazolin sodium) 1 gram/1 vial powder for conventional release solution for injection Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely voriconazole 50 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely diclofenac sodium 100 milligram/1 each conventional release rectal suppository Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely pivmecillinam 200 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely morphine sulfate 20 milligram/1 each conventional release rectal suppository Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely miconazole nitrate 20 milligram/1 gram conventional release vaginal cream Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely delavirdine mesilate 100 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely paracetamol 24 milligram/1 milliliter conventional release oral solution Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely framycetin sulfate 5 milligram/1 gram conventional release eye ointment Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely felbinac 31.7 milligram/1 gram conventional release transdermal foam Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely pantoprazole (as pantoprazole sodium sesquihydrate) 40 milligram/1 each gastro-resistant oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely doxorubicin hydrochloride 10 milligram/1 vial powder for conventional release solution for injection Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely clonazepam 2 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely bendroflumethiazide 5 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely amiodarone hydrochloride 200 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier

    Start Previous Page 225 of 342 Next End

    This concept is not in any reference sets

    Back to Start